Verify the current MAC LCD for the most recent coverage determination before billing semaglutide or tirzepatide for non-diabetes indications Source: CMS LCD Database RCM teams managing injection billing must verify that their billing software reflects the April 2026 quarterly MPFSDB update
4.3 Other amino acids and peptides with exercise in aging Beyond glycine and its derivatives, several amino acids and peptides have been studied for their potential to enhance exercise adaptations and counteract age-related declines in muscle function and health
Additionally, Tirzepatide has been proven to lower the risk of major cardiovascular events in individuals with type 2 diabetes and other related health conditions
Start your intake What the Research Shows About GLP-1 Medications and Breastfeeding Tirzepatide and semaglutide are newer GLP-1 receptor agonists developed primarily for type 2 diabetes and weight management in non-pregnant, non-lactating adults
We keep that claim grounded
Why Tirzepatide Causes Nausea and How Your Body Adapts Tirzepatide activates GLP-1 and GIP receptors throughout the gastrointestinal tract, slowing stomach emptying and signaling fullness to the brain's appetite centers
